4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001517
Options or other derivatives
- Director acquired 8,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Quimi Daphne Director | 2022-01-06 | Grant or award · Stock Option (Right to Buy) | +8,400 | 8,400 | D | ||
Loading xslF345X03/doc4.xml…